Historical Stock Chart
1 Year : From Oct 2017 to Oct 2018
Dr. Narasimhan, a U.S. citizen of Indian descent, joined Novartis in 2005 from consultancy McKinsey & Co., and rose quickly through the Swiss drugmaker's ranks to become chief medical officer and global head of drug development. "Novartis CEO Steers Drug Maker Back to R&D," at 09:02 GMT, incorrectly said Dr. Narasimhan is a U.S. citizen of Indian descent. A previous version of this story incorrectly said he was born in India. Dr. Narasimhan was Novartis' chief medical officer and global head of drug development. The earlier version of the story incorrectly said he was head of the company's research and development.
(END) Dow Jones Newswires
February 19, 2018 07:16 ET (12:16 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.